Myelodysplasia and Acute Leukemia as Late Complications of Marrow Failure: Future Prospects for Leukemia Prevention

被引：7

作者：

Bagby, Grover C. ^{[1
,3
,4
]}

Meyers, Gabrielle ^{[1
,2
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA

[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Hematol Malignancies Program, Portland, OR 97201 USA

[3] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA

[4] VA Med Ctr Portland, NW VA Canc Res Ctr, Portland, OR 97239 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2009年 / 23卷 / 02期

基金：

美国国家卫生研究院;

关键词：

Clonal evolution; Myelodysplasia; Aplastic anemia; Natural selection; Fanconi's anemia; Apoptosis; Leukemogenesis; TUMOR-NECROSIS-FACTOR; ACQUIRED APLASTIC-ANEMIA; COLONY-STIMULATING-FACTOR; STEM-CELL TRANSPLANTATION; BONE-MARROW; FANCONI-ANEMIA; FACTOR-ALPHA; TNF-ALPHA; IMMUNOSUPPRESSIVE THERAPY; CYTOGENETIC ABNORMALITIES;

D O I：

10.1016/j.hoc.2009.01.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients who have acquired and inherited bone marrow failure syndromes are at risk for the development of clonal neoplasms including acute myeloid leukemia, myelodysplastic syndrome, and paroxysmal nocturnal hemoglobinuria. This article reviews the evidence supporting a model of clonal selection, a paradigm that provides a reasonable expectation that these often fatal complications might be prevented in the future.

引用

收藏

页码：361 / +

页数：17

相关论文

共 82 条

[21] Commentary: Carcinogenesis as Darwinian evolution? Do the math! [J].

Gatenby, Robert A. .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (05) :1165-1167

[22] Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML [J].

Gondek, Lukasz P. ;

Tiu, Ramon ;

O'Keefe, Christine L. ;

Sekeres, Mikkael A. ;

Theil, Karl S. ;

Maciejewski, Jaroslaw R. .

BLOOD, 2008, 111 (03) :1534-1542

[23] Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cells [J].

Gregory, JJ ;

Wagner, JE ;

Verlander, PC ;

Levran, O ;

Batish, SD ;

Eide, CR ;

Steffenhagen, A ;

Hirsch, B ;

Auerbach, AD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2532-2537

[24]

Guinan Eva C, 2005, Hematology Am Soc Hematol Educ Program, P104

[25] Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning [J].

Gupta, V ;

Ball, SE ;

Sage, D ;

Ortin, M ;

Freires, M ;

Gordon-Smith, EC ;

Marsh, JCW .

BONE MARROW TRANSPLANTATION, 2005, 35 (05) :467-471

[26] Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution [J].

Haneline, LS ;

Li, XX ;

Ciccone, SLM ;

Hong, P ;

Yang, YZ ;

Broxmeyer, HE ;

Lee, SH ;

Orazi, A ;

Srour, EF ;

Clapp, DW .

BLOOD, 2003, 101 (04) :1299-1307

[27]

Haneline LS, 1998, BLOOD, V91, P4092

[28] Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up [J].

Kahl, C ;

Leisenring, W ;

Deeg, HJ ;

Chauncey, TR ;

Flowers, MED ;

Martin, PJ ;

Sanders, JE ;

Storb, R .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) :747-751

[29] Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling [J].

Kamarajan, P ;

Sun, NK ;

Chao, CCK .

BIOCHEMICAL JOURNAL, 2003, 376 :253-260

[30] Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia [J].

Kang, HJ ;

Shin, HY ;

Choi, HS ;

Ahn, HS .

BONE MARROW TRANSPLANTATION, 2004, 34 (11) :939-943

← 1 2 3 4 5 6 7 8 9 →